Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jul 1;100(7):432-443.
doi: 10.1097/OPX.0000000000002039. Epub 2023 Jul 1.

A Pilot Randomized Clinical Trial of Base-in Relieving Prism Spectacle Treatment of Intermittent Exotropia

Affiliations
Randomized Controlled Trial

A Pilot Randomized Clinical Trial of Base-in Relieving Prism Spectacle Treatment of Intermittent Exotropia

Allison I Summers et al. Optom Vis Sci. .

Abstract

Significance: This pilot randomized trial, the first to evaluate a specific base-in relieving prism treatment strategy for childhood intermittent exotropia, did not support proceeding to a full-scale clinical trial. Defining and measuring prism adaptation in children with intermittent exotropia are challenging and need further study.

Purpose: This study aimed to determine whether to proceed to a full-scale trial of relieving base-in prism spectacles versus refractive correction alone for children with intermittent exotropia.

Methods: Children 3 years old to those younger than 13 years with distance intermittent exotropia control score of ≥2 points on the Intermittent Exotropia Office Control Scale (Strabismus 2006;14:147-150; 0 [phoria] to 5 [constant]), ≥1 episode of spontaneous exotropia, and 16 to 35∆ by prism-and-alternate-cover test, who did not fully prism adapt on a 30-minute in-office prism-adaptation test were randomized to base-in relieving prism (40% of the larger of distance and near exodeviations) or nonprism spectacles for 8 weeks. A priori criteria to conduct a full-scale trial were defined for the adjusted treatment group difference in mean distance control: "proceed" (≥0.75 points favoring prism), "uncertain" (>0 to <0.75 points favoring prism), or "do not proceed" (≥0 points favoring nonprism).

Results: Fifty-seven children (mean age, 6.6 ± 2.2 years; mean baseline distance control, 3.5 points) received prism (n = 28) or nonprism (n = 29) spectacles. At 8 weeks, mean control values were 3.6 and 3.3 points in prism (n = 25) and nonprism (n = 25) groups, respectively, with an adjusted difference of 0.3 points (95% confidence interval, -0.5 to 1.1 points) favoring nonprism (meeting our a priori "do not proceed" criterion).

Conclusions: Base-in prism spectacles, equal to 40% of the larger of the exodeviations at distance or near, worn for 8 weeks by 3- to 12-year-old children with intermittent exotropia did not yield better distance control than refractive correction alone, with the confidence interval indicating that a favorable effect of 0.75 points or larger is unlikely. There was insufficient evidence to warrant a full-scale randomized trial.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: None of the authors have reported a financial conflict of interest.

Figures

Figure 1.
Figure 1.
Flow of Study Participants.

References

    1. Mohney BG, Holmes JM. An Office-Based Scale for Assessing Control in Intermittent Exotropia. Strabismus 2006;14:147–50. - PMC - PubMed
    1. Pediatric Eye Disease Investigator Group. A Randomized Trial Comparing Part-Time Patching with Observation for Children 3 to 10 Years of Age with Intermittent Exotropia. Ophthalmology 2014;121:2299–310. - PMC - PubMed
    1. Pediatric Eye Disease Investigator Group. A Randomized Trial Comparing Part-Time Patching with Observation for Intermittent Exotropia in Children 12 to 35 Months of Age. Ophthalmology 2015;122:1718–25. - PMC - PubMed
    1. Pediatric Eye Disease Investigator Group. A Randomized Trial Evaluating Short-Term Effectiveness of Overminus Lenses in Children 3 to 6 Years of Age with Intermittent Exotropia. Ophthalmology 2016;123:2127–36. - PMC - PubMed
    1. Chen AM, Erzurum SA, Chandler DL, et al. Overminus Lens Therapy for Children 3 to 10 Years of Age with Intermittent Exotropia: A Randomized Clinical Trial. JAMA Ophthalmol 2021;139:464–76. - PMC - PubMed

Publication types